Cite
HARVARD Citation
Ozdemir, Y. et al. (2022). In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency. Applied immunohistochemistry & molecular morphology. 30 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ozdemir, Y. et al. (2022). In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency. Applied immunohistochemistry & molecular morphology. 30 (2), p. . [Online].